Cervical cancer vaccine controversy in India

2018 ◽  
Vol 19 (2) ◽  
pp. e84 ◽  
Author(s):  
Manjulika Das
Sexual Health ◽  
2010 ◽  
Vol 7 (3) ◽  
pp. 230 ◽  
Author(s):  
Ian H. Frazer

Cervical cancer is initiated by infection of cervical epithelium with human papillomavirus. Vaccines have been developed, incorporating papillomavirus viral capsids and alum based adjuvants. In extensive clinical trials these vaccines have been shown safe and effective in preventing infection with, and disease caused by, the papillomavirus genotypes they incorporate, in women not already infected. These vaccines have the potential to reduce the global burden of cervical cancer by up to 70%.


2019 ◽  
Vol 4 (2) ◽  
pp. 252-262
Author(s):  
Yani Suryani ◽  
Opik Taupiqurrohman ◽  
Muhammad Yusuf ◽  
Toto Subroto ◽  
Sukma Nuswantara

 The aims of this study were to carry out testing of the early 4 protein of type 16 HPV through immunoinformatics meth-ods in an effort to get the peptide vaccine candidate for cervical cancer. The software used are IEDB-AR, CABSdock and Accelrys Discovery Study 4.5. Based on the analysis that sequence of ami-no acid lysine, leucine, leucine, glycine, serine, threonine, tryp-tophan, proline and threonine (KLLGSTWPT) and the sequence of amino acid tyrosine, tyrosine, valine, leucine, histidine, leucine, cysteine, leucine, alanine, alanine, threonine, lysine, tyrosine, pro-line and leucine (YYVLHLCLAATKYPL) are peptide vaccine can-didate for cervical cancer from the early 4 protein of HPV type 16 


2008 ◽  
Vol 12 (10) ◽  
pp. 20-57

Taking One for the Girls – Meina Lee tells APBN why boys might want to consider taking the cervical cancer vaccine. Catching Cancer Early By Dr Achim Plum. APBN speaks with Dr Axel Ullrich, research director of the Singapore OncoGenome Project at A*STAR's Institute of Medical Biology and director of Molecular Biology at the Max Planck Institute of Biochemistry, who sheds more light on the cancer challenges ahead. APBN speaks to Professor Soo Khee Chee, director of National Cancer Center, about the much dreaded disease. APBN chats with Dr Susan Lim, who is widely known in Asia and Singapore for being the first surgeon to have performed a successful liver transplant. Cancer Research in Asia Pacifc by Serene Ong.


2008 ◽  
Vol 12 ◽  
pp. e150 ◽  
Author(s):  
T.F. Schwarz ◽  
J. Garcia-Sicilia ◽  
A. Carmona ◽  
J.E. Malkin ◽  
M.P. Tran ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document